Biotech ETFs In Focus On String Of Q2 Earnings Beats
August 12, 2018 at 17:27 PM EDT
The biotech sector has been performing remarkably well driven by a wave of mergers and acquisitions, new tax legislation, and a positive regulatory backdrop. Strong Q2 earnings results have added to the strength as biotech giants topped estimates.